| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $20,727,104 | 57 | 100 |
| Hoff Elizabeth A | director | 0 | $0 | 1 | $189,412 | $-189,412 |
| Berry Lance A | EVP, COO, CFO & Treasurer | 0 | $0 | 5 | $803,205 | $-803,205 |
| Horton Amy | VP, Chief Accounting Officer | 0 | $0 | 8 | $870,064 | $-870,064 |
| GREEN ANDREW M | SVP, Regulatory and Quality | 0 | $0 | 5 | $1.43M | $-1.43M |
| Davis John E | Chief Commercial Officer | 0 | $0 | 9 | $1.75M | $-1.75M |
| Holloway Jean F | SVP, General Counsel | 0 | $0 | 12 | $2.54M | $-2.54M |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 0 | $0 | 8 | $3.43M | $-3.43M |
| Mackin James P | President & CEO | 0 | $0 | 9 | $9.72M | $-9.72M |
Artivion Inc. is a global company that develops, produces, and supplies medical devices and implantable human tissues. Its product range includes BioGlue, a polymer derived from bovine blood protein combined with a cross-linking agent, utilized in cardiac, vascular, neurological, and pulmonary surgical applications. The company also offers heart preservation services and the PhotoFix bovine pericardial patch, in addition to E-vita Open Plus and E-vita Open Neo devices. For the treatment of aortic vascular conditions, Artivion provides …
Over the last 12 months, insiders at Artivion, Inc. have bought $0 and sold $20.73M worth of Artivion, Inc. stock.
On average, over the past 5 years, insiders at Artivion, Inc. have bought $161,969 and sold $8.25M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,100 shares for transaction amount of $53,141 was made by SEMEDO ANTHONY B. (director) on 2025‑03‑05.
| 2026-09-10 | Sale | GREEN ANDREW M | SVP, Regulatory and Quality | 11,480 0.024% | $24.97 | $286,656 | -6.98% | |
| 2026-09-03 | Sale | GREEN ANDREW M | SVP, Regulatory and Quality | 1,493 0.0031% | $26.02 | $38,842 | -10.36% | |
| 2026-09-02 | Sale | GREEN ANDREW M | SVP, Regulatory and Quality | 6,510 0.0139% | $27.27 | $177,495 | -12.76% | |
| 2026-08-19 | Sale | Mackin James P | President & CEO | 70,000 0.1449% | $28.95 | $2.03M | -18.67% | |
| 2026-08-14 | Sale | Berry Lance A | EVP, COO, CFO & Treasurer | 715 0.0014% | $28.55 | $20,413 | -19.17% | |
| 2026-08-14 | Sale | GREEN ANDREW M | SVP, Regulatory and Quality | 616 0.0012% | $28.55 | $17,586 | -19.17% | |
| 2026-08-12 | Sale | Holloway Jean F | SVP, General Counsel | 977 0.002% | $28.49 | $27,835 | -17.58% | |
| 2026-06-11 | Sale | GREEN ANDREW M | SVP, Regulatory and Quality | 44,001 0.0911% | $20.70 | $910,739 | +16.80% | |
| 2026-03-04 | Sale | Holloway Jean F | SVP, General Counsel | 8,962 0.0184% | $38.00 | $340,556 | -34.91% | |
| 2026-03-03 | Sale | Mackin James P | President & CEO | 17,887 0.0366% | $37.78 | $675,692 | -35.09% | |
| 2026-03-03 | Sale | Davis John E | Chief Commercial Officer | 4,573 0.0094% | $37.78 | $172,748 | -35.09% | |
| 2026-03-03 | Sale | Berry Lance A | EVP, COO, CFO & Treasurer | 6,316 0.0129% | $37.78 | $238,591 | -35.09% | |
| 2026-03-03 | Sale | Holloway Jean F | SVP, General Counsel | 3,843 0.0079% | $37.78 | $145,172 | -35.09% | |
| 2026-03-03 | Sale | Horton Amy | VP, Chief Accounting Officer | 901 0.0018% | $37.78 | $34,036 | -35.09% | |
| 2026-03-03 | Sale | Stanton Marshall S. | SVP, Clinical & MD Affair | 2,149 0.0044% | $37.78 | $81,180 | -35.09% | |
| 2026-03-02 | Sale | Mackin James P | President & CEO | 14,911 0.0308% | $38.02 | $566,989 | -34.94% | |
| 2026-03-02 | Sale | Davis John E | Chief Commercial Officer | 2,784 0.0057% | $38.02 | $105,861 | -34.94% | |
| 2026-03-02 | Sale | Berry Lance A | EVP, COO, CFO & Treasurer | 5,178 0.0107% | $38.02 | $196,893 | -34.94% | |
| 2026-03-02 | Sale | Holloway Jean F | SVP, General Counsel | 2,183 0.0045% | $38.02 | $83,008 | -34.94% | |
| 2026-03-02 | Sale | Horton Amy | VP, Chief Accounting Officer | 641 0.0013% | $38.02 | $24,374 | -34.94% |
| Mackin James P | President & CEO | 877275 1.7993% | $20.8M | 4 | 28 | +33.26% |
| Davis John E | Chief Commercial Officer | 230794 0.4734% | $5.47M | 2 | 30 | +28.47% |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 347217 0.7121% | $8.23M | 2 | 19 | +25.04% |
| SEMEDO ANTHONY B. | director | 39384 0.0808% | $933,794.64 | 2 | 2 | +32.95% |
| Bullock James | director | 34023 0.0698% | $806,685.33 | 1 | 0 | +47.76% |
| Increased Positions | 127 | +56.19% | 7M | +15.71% |
| Decreased Positions | 95 | -42.04% | 6M | -14.08% |
| New Positions | 39 | New | 1M | New |
| Sold Out Positions | 16 | Sold Out | 4M | Sold Out |
| Total Postitions | 258 | +14.16% | 43M | +1.63% |
| Blackrock, Inc. | $268,967.00 | 12.87% | 6.05M | +48,727 | +0.81% | 2025-09-30 |
| Vanguard Group Inc | $134,672.00 | 6.45% | 3.03M | +232,424 | +8.31% | 2025-09-30 |
| Fmr Llc | $132,854.00 | 6.36% | 2.99M | +700,131 | +30.6% | 2025-09-30 |
| Macquarie Group Ltd | $110,432.00 | 5.29% | 2.48M | -472,724 | -15.99% | 2025-09-30 |
| Morgan Stanley | $99,523.00 | 4.76% | 2.24M | -80,166 | -3.46% | 2025-09-30 |
| Perceptive Advisors Llc | $89,809.00 | 4.3% | 2.02M | -773,703 | -27.7% | 2025-09-30 |
| State Street Corp | $68,481.00 | 3.28% | 1.54M | +25,417 | +1.68% | 2025-09-30 |
| Wellington Management Group Llp | $66,738.00 | 3.19% | 1.5M | -212,336 | -12.39% | 2025-09-30 |
| Juniper Investment Company, Llc | $59,296.00 | 2.84% | 1.33M | -760,257 | -36.31% | 2025-09-30 |
| Fred Alger Management, Llc | $58,565.00 | 2.8% | 1.32M | -33,709 | -2.5% | 2025-09-30 |